Discover 420 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 420
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
for
Osteoarthritis (OA) of the Knee
Location: 24 recruiting locations
Sponsor: OrthoTrophix, Inc
Sex: All
Age: 50 - 70+
Code: NCT06865079
Phase2, Recruiting
Active & Responsive
The Effects of Sex Hormones and Alcohol on Sleep
for
Alcohol Use Disorder
Location: 1 recruiting location
Sponsor: Lauren Whitehurst
Sex: All
Age: 21 - 45
Code: NCT06143059
Phase3, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: 15 recruiting locations
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
for
Myasthenia Gravis
Location: 9 recruiting locations
Sponsor: Ad scientiam
Sex: All
Age: 18+
Code: NCT05564936
Recruiting
Active & Responsive
Blood Flow Restriction Training After Patellar INStability
for
Patellar Dislocation, Knee Injuries, Leg Injury,
Location: 2 recruiting locations
Sponsor: Caitlin Conley
Sex: All
Age: 14 - 40
Code: NCT04554212
Recruiting
Active & Responsive
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
for
Multiple System Atrophy, Parkinsons Disease
Location: 1 recruiting location
Sponsor: Craig van Horne, MD, PhD
Sex: All
Age: 40 - 70+
Code: NCT06683365
Phase1, Recruiting
Active & Responsive
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer